| Challenges of advanced hepatocellular carcinoma S Colagrande, AL Inghilesi, S Aburas, GG Taliani, C Nardi, F Marra World journal of gastroenterology 22 (34), 7645, 2016 | 211 | 2016 |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017 | 96 | 2017 |
| A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma G Cabibbo, S Petta, M Barbàra, G Missale, R Virdone, E Caturelli, ... Liver International 37 (8), 1157-1166, 2017 | 92 | 2017 |
| The evolutionary scenario of hepatocellular carcinoma in Italy: an update L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ... Liver International 37 (2), 259-270, 2017 | 84 | 2017 |
| Radiation therapy for atypical and anaplastic meningiomas: an overview of current results and controversial issues L Vagnoni, S Aburas, M Giraffa, I Russo, V Chiarella, S Paolini, P Tini, ... Neurosurgical Review 45 (5), 3019-3033, 2022 | 20 | 2022 |
| Metabolic disorders across hepatocellular carcinoma in Italy F Morisco, M Guarino, MR Valvano, F Auriemma, F Farinati, EG Giannini, ... Liver International 38 (11), 2028-2039, 2018 | 11 | 2018 |
| Time-varying mHAP III is the most accurate score in predicting survival in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE) C Campani, A Vitale, G Dragoni, S Aburas, U Arena, G Laffi, U Cillo, ... Digestive and Liver Disease 51, e6, 2019 | 2 | 2019 |
| The ALBI and p-ALBI grades predict survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization (TACE) C Campani, A Vitale, G Dragoni, S Aburas, U Arena, EG Giannini, ... Digestive and Liver Disease 50 (1), 44, 2018 | 2 | 2018 |
| Dynamics of endothelial progenitor cells in patients with advanced hepatocellular carcinoma C Campani, M Capone, F Liotta, U Arena, V Adotti, C Di Bonaventura, ... Digestive and Liver Disease 54 (7), 911-917, 2022 | | 2022 |
| PS-119-Time-varying mHAP III is the most accurate score in predicting survival in patients wit hepatocellular carcinoma undergoing trans-arterial chemoembolization C Campani, A Vitale, S Aburas, G Dragoni, U Arena, EG Giannini, U Cillo, ... Journal of Hepatology 70 (1), e75, 2019 | | 2019 |
| Role of Circulating Endothelial Progenitors cells (EPC) in patients with hepatocellular Carcinoma treated with Sorafenib S Aburas | | 2017 |
